Status:
RECRUITING
Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
Lead Sponsor:
Ludwig Boltzmann Institute for Lung Health
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung ...
Eligibility Criteria
Inclusion
- diagnosis of interstitial lung disease
- written informed consent
Exclusion
- to not comprehend and rightfully judge participation
Key Trial Info
Start Date :
February 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2034
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06522334
Start Date
February 28 2024
End Date
February 28 2034
Last Update
March 14 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Hietzing
Vienna, Austria, 1130
2
Klinik Penzing
Vienna, Austria, 1140
3
Ludwig Boltzmann Institut for Lung Health
Vienna, Austria, 1140
4
Klinik Ottakring
Vienna, Austria, 1160